Updated:
Sunz Fund
Sunz Fund is a venture capital firm that invests in life science, medical health, and resources environment sectors. The firm has made 31 investments,...
Sunz Fund
Sunz Fund is a venture capital firm that invests in life science, medical health, and resources environment sectors. The firm has made 31 investments, including a Seed VC investment in INFINITY SCOPE on March 24, 2026. Sunz Fund has facilitated 4 portfolio exits, with CiDi exiting on December 19, 2025.
General information
Firm type
Private Equity
Year founded
2008
Location
Region
Asia
Country
China
City
Beijing
Corporate office
Beijing, China
Frequently asked questions
What investment stages does Sunz Fund target?
Sunz Fund covers the full spectrum from early-stage venture to pre-IPO. Its stated strategy includes seed, startup, growth, and expansion-stage investments, per the firm's official website. This stage-agnostic approach allows the firm to maintain exposure to portfolio companies as they scale.
Is Sunz Fund focused exclusively on the Chinese market?
Based on its Beijing headquarters and stated investment mandate, Sunz Fund's operations appear concentrated on mainland China. The firm has not disclosed any international offices or cross-border investment programs in public record.
How does Sunz Fund structure its investments?
Sunz Fund operates as a direct private equity investor, deploying capital into private companies across venture and growth stages. There is no public indication that the firm participates in fund-of-funds commitments or operates a co-investment club model alongside external allocators.
Who runs investment decisions at Sunz Fund?
Sunz Fund has not publicly disclosed its leadership team or investment committee structure. Principal names and professional backgrounds are not available through the firm's official communications or independent public record.
What is Sunz Fund's known posture on co-investments alongside external GPs?
There is no public evidence that Sunz Fund engages in co-investment partnerships with external general partners. The firm's stated strategy emphasizes direct equity positions, and it has not publicized any co-investor relationships or club-deal participation.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: